Metphar XR is used together with diet and exercise to lower the risk of developing Type 2 diabetes in overweight adults, when diet and exercise alone for 3 to 6 months have not been enough to control blood glucose (sugar). Patients are at high risk of developing Type 2 diabetes if they have additional conditions like high blood pressure, aged above 40 years, an abnormal amount of lipids (fat) in the blood or a history of diabetes during pregnancy.
The medicine is particularly effective if patients are aged below 45 years, are very overweight, have high blood glucose levels after a meal or developed diabetes during pregnancy.
Metphar XR is used for the treatment of Type 2 diabetes when diet and exercise changes alone have not been enough to control blood glucose (sugar). Insulin is a hormone that enables body tissues to take glucose from the blood and to use it for energy for storage for future use. People with Type 2 diabetes do not make enough insulin in their pancreas or their body does not respond properly to the insulin it does make. This causes a build-up of glucose in the blood which can cause a number of serious long-term problems so it is important that patients continue to take the medicine, even though they may not have any obvious symptoms. Metphar XR makes the body more sensitive to insulin and helps return to normal the way the body uses glucose.
Metphar XR is associated with either a stable body weight or modest weight loss.
Metphar XR extended-release tablets are specially made to release the drug slowly in the body and therefore are different to many other types of tablet containing metformin.